Production (Stage)
BioAge Labs, Inc.
BIOA
$3.98
$0.030.76%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 10.61% | 29.72% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -29.43% | 2.47% | |||
| Operating Income | 35.15% | -2.47% | |||
| Income Before Tax | 38.81% | 9.73% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 38.81% | 9.73% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 38.81% | 9.73% | |||
| EBIT | 35.15% | -2.47% | |||
| EBITDA | 35.18% | -2.44% | |||
| EPS Basic | 38.54% | 91.24% | |||
| Normalized Basic EPS | 38.73% | 91.21% | |||
| EPS Diluted | 38.54% | 91.24% | |||
| Normalized Diluted EPS | 38.73% | 91.21% | |||
| Average Basic Shares Outstanding | -0.46% | 930.56% | |||
| Average Diluted Shares Outstanding | -0.46% | 930.56% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||